1. Home
  2. NG vs INVA Comparison

NG vs INVA Comparison

Compare NG & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NG
  • INVA
  • Stock Information
  • Founded
  • NG 1984
  • INVA 1996
  • Country
  • NG Canada
  • INVA United States
  • Employees
  • NG N/A
  • INVA N/A
  • Industry
  • NG Precious Metals
  • INVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NG Basic Materials
  • INVA Health Care
  • Exchange
  • NG Nasdaq
  • INVA Nasdaq
  • Market Cap
  • NG 1.2B
  • INVA 1.2B
  • IPO Year
  • NG N/A
  • INVA 2004
  • Fundamental
  • Price
  • NG $3.30
  • INVA $17.68
  • Analyst Decision
  • NG
  • INVA Buy
  • Analyst Count
  • NG 0
  • INVA 1
  • Target Price
  • NG N/A
  • INVA N/A
  • AVG Volume (30 Days)
  • NG 1.5M
  • INVA 625.6K
  • Earning Date
  • NG 01-23-2025
  • INVA 02-27-2025
  • Dividend Yield
  • NG N/A
  • INVA N/A
  • EPS Growth
  • NG N/A
  • INVA 46.55
  • EPS
  • NG N/A
  • INVA 0.99
  • Revenue
  • NG N/A
  • INVA $352,745,000.00
  • Revenue This Year
  • NG N/A
  • INVA $16.20
  • Revenue Next Year
  • NG N/A
  • INVA N/A
  • P/E Ratio
  • NG N/A
  • INVA $17.85
  • Revenue Growth
  • NG N/A
  • INVA 21.46
  • 52 Week Low
  • NG $2.23
  • INVA $14.33
  • 52 Week High
  • NG $4.88
  • INVA $21.28
  • Technical
  • Relative Strength Index (RSI)
  • NG 45.09
  • INVA 41.38
  • Support Level
  • NG $3.29
  • INVA $17.01
  • Resistance Level
  • NG $3.55
  • INVA $17.53
  • Average True Range (ATR)
  • NG 0.13
  • INVA 0.26
  • MACD
  • NG 0.00
  • INVA 0.05
  • Stochastic Oscillator
  • NG 32.89
  • INVA 69.07

About NG Novagold Resources Inc.

Novagold Resources Inc is a mineral exploration company engaged in the exploration and development of mineral properties. The company owns 50% of the Donlin Gold project, which is located in southwestern Alaska, approximately 20 kilometers north of the village of Crooked Creek on the Kuskokwim River.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Share on Social Networks: